Aberrant promoter methylation of HIV‐1 TAT‐interactive protein 2 (HTATIP2) attenuates the negative regulatory capacity of glioblastoma cells to reduce nuclear translocation of cancer‐relevant proteins such as the base excision repair enzyme N‐methylpurine DNA glycosylase (MPG). This evidence concerns the gene HTATIP2 and cancer.